Candel Therapeutics (CADL) Leases (2022 - 2023)
Candel Therapeutics' Leases history spans 2 years, with the latest figure at $879000.0 for Q3 2023.
- For Q3 2023, Leases fell 20.81% year-over-year to $879000.0; the TTM value through Sep 2023 reached $879000.0, down 20.81%, while the annual FY2022 figure was $1.1 million, N/A changed from the prior year.
- Leases for Q3 2023 was $879000.0 at Candel Therapeutics, down from $940000.0 in the prior quarter.
- Across five years, Leases topped out at $1.2 million in Q1 2022 and bottomed at $879000.0 in Q3 2023.